ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress
ROCKVILLE,Md. and SUZHOU,China,Sept. 9,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing and commercializing both first-in-class and best-in-class